clinical trial · NCT07699471
A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
HypoparathyroidismCanvuparatidePlacebo
brief summary
The purpose of this study is to investigate the efficacy and safety of canvuparatide administered as a once-weekly (QW) treatment to adult study participants with hypoparathyroidism (HypoPT).
started
Aug 26, 2026
primary completion
Jan 1, 2028
completion
Aug 1, 2029
last updated
Oct 23, 2026
official title
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Followed by an Open-Label Extension to Evaluate the Safety and Efficacy of Canvuparatide (MBX 2109) in Adult Patients With Hypoparathyroidism
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol